Ultrasound: More Harm than Good?
by Marsden Wagner
© 1999 Midwifery Today, Inc. All rights reserved.
[Editor's note: This article first appeared in
Midwifery Today, Issue 50, Summer 1999.]
The ultrasound story begins in July 1955 when an obstetrician in Scotland,
Ian Donald, borrowed an industrial ultrasound machine used to detect flaws
in metal and tried it out on some tumours, which he had removed previously,
using a beefsteak as the control. He discovered that different tumours
produced different echoes. Soon Donald was using ultrasound not only for
abdominal tumours in women but also on pregnant women. Articles surfaced
in the medical journals, and its use quickly spread throughout the world.
The dissemination of ultrasound into clinical obstetrics is reflected
in inappropriate statements made in the obstetrical literature regarding
its appropriate use: "One of the lessons of history is, of course,
that it repeats itself. The development of obstetric ultrasound thus mirrors
the application to human pregnancy of diagnostic X-rays. Both, within
a few years of discovery, were being used to diagnose pregnancy and to
measure the growth and normality of the fetus. In 1935 it was said that
"antenatal work without the routine use of X-rays is no more justifiable
than would be the treatment of fractures" (Reece, 1935: 489). In
1978: "It can be stated without qualification that modern obstetrics
and gynecology cannot be practiced without the use of diagnostic ultrasound"
(Hassani, 1978). Two years later, it was said that "ultrasound is
now no longer a diagnostic test applied to a few pregnancies regarded
on clinical grounds as being at risk. It can now be used to screen all
pregnancies and should be regarded as an integral part of antenatal care"
(Campbell & Little, 1980). On neither of these dates did evidence
qualify the speakers to make these assertions.
It is not only doctors who have tried to promote ultrasound with statements
that go beyond the scientific data. Commercial interests also have been
actively promoting ultrasound, and not only to doctors and hospitals.
As an example, an advertisement in a widely read Sunday newspaper (The
Times, London) claimed: Toshiba decided to design a diagnostic piece of
equipment that would be absolutely safe . . . .The name: Ultrasound. A
consumer organization in Britain complained to the Advertising Standards
Authority that Toshiba was making an untrue claim, and the complaint was
upheld. In many countries, the commercial application of ultrasound scanning
during pregnancy is widespread, offering "baby look" and "fun
ultrasound" in order to "meet your baby" with photographs
and home videos.
The extent to which medical practitioners nevertheless followed such
scientifically unjustified advice, and the degree to which this technology
proliferated, can be illustrated by recent data from three countries.
In France, in one year three million ultrasound examinations were done
on 700,000 pregnant women-an average of more than four scans per pregnancy.
These examinations cost French taxpayers more than all other therapeutic
and diagnostic procedures done on these pregnant women. In Australia,
where the health service pays for four routine scans, in one recent year
billing for obstetrical ultrasound was $60 million in Australian dollars.
A 1993 editorial in U.S.A. Today makes the following statement: "Baby's
first picture-a $200 sonogram shot in the womb-is a nice addition to any
family album. But are sonograms medically worth $1 billion of the nation's
scarce health-care dollars? That's the question raised by a United States
study released this week. It found the sonograms that doctors routinely
perform on healthy pregnant women don't make any difference to the health
of their babies."
After a technology has spread widely in clinical practice, the next
step is for health policymakers to accept it as standard care financed
by the official health sector.
Several European countries now have official policy for one or more
routine ultrasound scans during pregnancy. For example, in 1980 the Maternity
Care Guidelines in West Germany stated the right of each pregnant woman
to be offered at least two ultrasound scans during pregnancy. Austria
quickly followed suit, approving two routine scans. Do the scientific
data justify such widespread use and great cost of ultrasound scanning?
When is Ultrasound Helpful?
In assessing the effectiveness of ultrasound in pregnancy, it is essential
to make the distinction between its selective use for specific indications
and its routine use as a screening procedure.
Essentially, ultrasound has proven valuable in a handful of specific
situations in which the diagnosis "remains uncertain after clinical
history has been ascertained and a physical examination has been performed."
Yet, considering whether the benefits outweigh the costs of using ultrasound
routinely, systematic medical research has not supported routine use.
One of the most common justifications given today for routine ultrasound
scanning is to detect intrauterine growth retardation (IUGR). Many clinicians
insist that ultrasound is the best method for the identification of this
condition. In 1986, a professional review of 83 scientific articles on
ultrasound showed that "for intrauterine growth retardation detection,
ultrasound should be performed only in a high-risk population." In
other words, the hands of an experienced midwife or doctor feeling a pregnant
woman's abdomen are as accurate as the ultrasound machine for detecting
IUGR. The same conclusion was reached by a study in Sweden comparing repeated
measurement of the size of the uterus by a midwife with repeated ultrasonic
measurements of the head size of the fetus in 581 pregnancies. The report
concludes: "Measurements of uterus size are more effective than ultrasonic
measurements for the antenatal diagnosis of intrauterine growth retardation."
If doctors continue to try to detect IUGR with ultrasound, the result
will be high false-positive rates. Studies show that even under ideal
conditions, such as do not exist in most settings, it is likely that over
half of the time a positive IUGR screening test using ultrasound is returned,
the test is false, and the pregnancy is in fact normal. The implications
of this are great for producing anxiety in the woman and the likelihood
of further unnecessary interventions.
There is another problem in screening for IUGR. One of the basic principles
of screening is to screen only for conditions for which you can do something.
At present, there is no treatment for IUGR, no way to slow up or stop
the process of too-slow growth of the fetus and return it to normal. So
it is hard to see how screening for IUGR could be expected to improve
pregnancy outcome.
We are left with the conclusion that, with IUGR, we can only prevent
a small amount of it using social interventions (nutrition and substance
abuse programs), are very inaccurate at diagnosing it, and have no treatment
for it. If this is the present state of the art, there is no justification
for clinicians using routine ultrasound during pregnancy for the management
of IUGR. Its use should be limited to research on IUGR.
Once again it is interesting to look at what happened with the issue
of safety of X-rays during pregnancy. X-rays were used on pregnant women
for almost fifty years and assumed to be safe. In 1937, a standard textbook
on antenatal care stated: "It has been frequently asked whether there
is any danger to the life of the child by the passage of X- rays through
it; it can be said at once there is none if the examination is carried
out by a competent radiologist or radiographer." A later edition
of the same textbook stated: "It is now known that the unrestricted
use of X-rays through the fetus caused childhood cancer." This story
illustrates the danger of assuming safety. In this regard, a statement
from a 1978 textbook is relevant: "One of the great virtues of diagnostic
ultrasound has been its apparent safety. At present energy levels, diagnostic
ultrasound appears to be without injurious effect . . . all the available
evidence suggests that it is a very safe modality."
That ultrasound during pregnancy cannot be simply assumed to be harmless
is suggested by good scientific work in Norway. By following up on children
at age eight or nine born of mothers who had taken part in two controlled
trials of routine ultrasound in pregnancy, they were able to show that
routine ultrasonography was associated with a symptom of possible neurological
problems.
With regard to the active scientific pursuit of safety, an editorial
in Lancet, a British medical journal, says: "There have been no randomized
controlled trials of adequate size to assess whether there are adverse
effects on growth and development of children exposed in utero to ultrasound.
Indeed, the necessary studies to ascertain safety may never be done, because
of lack of interest in such research."
The safety issue is made more complicated by the problem of exposure
conditions. Clearly, any bio-effects that might occur as a result of ultrasound
would depend on the dose of ultrasound received by the fetus or woman.
But there are no national or international standards for the output characteristics
of ultrasound equipment. The result is the shocking situation described
in a commentary in the British Journal of Obstetrics and Gynaecology,
in which ultrasound machines in use on pregnant women range in output
power from extremely high to extremely low, all with equal effect. The
commentary reads, "If the machines with the lowest powers have been
shown to be diagnostically adequate, how can one possibly justify exposing
the patient to a dose 5,000 times greater?" It goes on to urge government
guidelines on the output of ultrasound equipment and for legislation making
it mandatory for equipment manufacturers to state the output characteristics.
As far as is known, this has not yet been done in any country.
Safety is also clearly related to the skill of the ultrasound operator.
At present, there is no known training or certification for medical users
of ultrasound apparatus in any country. In other words, the birth machine
has no license test for its drivers.
|
|
Understanding
Obstetric Ultrasound (2nd edition)
by Jean Proud |
Looking Ahead: Ultrasound and the Future
Although ultrasound is expensive, routine scanning is of doubtful usefulness,
and the procedure has not yet been proved to be safe, this technology
is widely used, and its use is increasing rapidly without control. Nevertheless,
health policy is slow to develop. No country is known to have developed
policies with regard to standards for the machines, nor for the training
and certification of the operators. A few industrialized countries have
begun to respond to the data showing lack of effectiveness for routine
scanning of all pregnant women. In the United States, for example, a consensus
conference on diagnostic ultrasound imaging in pregnancy concluded that
"the data on clinical effectiveness and safety do not allow recommendation
for routine screening at this time; there is a need for multidisciplinary
randomized controlled clinical trials for an adequate assessment."
Denmark, Sweden, and the United Kingdom have made similar statements
against routine screening. The World Health Organisation (WHO), in an
attempt to stimulate governments to develop policy on this issue, published
the following statement:
"The World Health Organisation stresses that health technologies
should be thoroughly evaluated prior to their widespread use. Ultrasound
screening during pregnancy is now in widespread use without sufficient
evaluation. Research has demonstrated its effectiveness for certain complications
of pregnancy, but the published material does not justify the routine
use of ultrasound in pregnant women. There is also insufficient information
with regard to the safety of ultrasound use during pregnancy. There is
as yet no comprehensive, multidisciplinary assessment of ultrasound use
during pregnancy, including: clinical effectiveness, psychosocial effects,
ethical considerations, legal implications, cost benefit, and safety.
"WHO strongly endorses the principle of informed choice with regard
to technology use. The health-care providers have the moral responsibility:
fully to inform the public about what is known and not known about ultrasound
scanning during pregnancy; and fully to inform each woman prior to an
ultrasound examination as to the clinical indication for ultrasound, its
hoped-for benefit, its potential risk, and alternative available, if any."
This statement, sadly, is as relevant today. During the 1980s and early 1990s,
a number of us were raising questions about both the effectiveness and safety of
fetal scanning. Our voice of caution, however, was like a cry in the wilderness
as the technology proliferated.
Then, during the course of one month in late 1993, two landmark scientific papers
were published. The first paper, a largely randomized trial of the effectiveness
of routine prenatal ultrasound screening, studied the outcome of more than 15,000
pregnant women who either received two routine scans at 15 to 22 weeks and 31 to
35 weeks, or were scanned only for medical indications.
Results showed that the mean number of sonograms in the ultrasound group
was 2.2 and in the control group (for indication only) was 0.6. The rate
of adverse outcome (fetal death, neonatal death, neonatal morbidity),
as well as the rate of preterm delivery and distribution of birth weights,
was the same for both groups. In addition, in the author's words: "The
ultrasonic detection of congenital abnormalities has no effect on perinatal
outcome." At last we have a randomized clinical trial of sufficient
size to conclude that there is no value to routine scanning during pregnancy.
The second landmark paper, also a randomized controlled trial, looked
at the safety of repeated prenatal ultrasound imaging. While the original
purpose of the trial was hopefully to demonstrate the safety of repeated
scanning, the results were the opposite. From 2,834 pregnant women, 1,415
received ultrasound imaging at 18, 24, 28, 34 and 38 weeks gestation (intensive
group) while the other 1,419 received single ultrasound imaging at 18
weeks (regular group). The only difference between the two groups was
significantly higher (one-third more) intrauterine growth retardation
in the intensive group. This important and serious finding prompted the
authors to state: "It would seem prudent to limit ultrasound examinations
of the fetus to those cases in which the information is likely to be of
clinical importance." Ironically, it is now likely that ultrasound
may lead to the very condition, IUGR, that it has for so long claimed
to be effective in detecting.
Although we now have sufficient scientific data to be able to say that
routine prenatal ultrasound scanning has no effectiveness and may very
well carry risks, it would be naive to think that routine use will not
continue.
Unfortunately, medical doctors are inadequately educated in the basics
of scientific method. It will be a struggle to close the gap between this
new scientific data and clinical practice.
|
|
Issue
51
Theme: Fathers in Pregnancy and Birth
Articles on ultrasound, natural family planning, the “call” to
midwifery, placenta previa and much more round out the issue.
|
References
- Beech, B. & Robinson, J. (1993). Ultrasound? Unsound. Association for the
Improvement in Maternity Services Journal 5.
- Campbell, S. & Little, D. (1980). Clinical potential of real-time ultrasound.
In M. Bennett & S. Campbell (Eds), Real-time Ultrasound in Obstetrics. Oxford:
Blackwell Scientific Publications.
- Chassar Moir, J. (1960). The uses and values of radiology in obstetrics. In
F. Browne & McClure-Brown (Eds), Antenatal and Postnatal Care (9th ed.). London:
J. & A. Churchill.
- Cnattingius, J. (1984). Screening for Intrauterine Growth Retardation. Doctoral
dissertation, Uppsala University, Sweden.
- Ewigman, B. G. et al. and RADIUS study group. (1993). Effect of prenatal ultrasound
screening on perinatal outcome. New England Journal of Medicine 329 (12).
- Hassani, S. (1978). Ultrasound in Gynecology and Obstetrics. New York: Springer
Verlag.
- National Institutes of Health. (1984). Diagnostic ultrasound imaging in pregnancy.
Consensus Development Conference Consensus Statement 5, No. 1. Washington, D.C.
- Neilson, J. & Grant, A. (1991). Ultrasound in pregnancy. In I. Chalmers
et al. (Eds), Effective Care in Pregnancy and Childbirth. Oxford, England: Oxford
University Press.
- Newnham, J. et al. (1993). Effects of frequent ultrasound during pregnancy:
A randomised controlled trial. Lancet.
- Newnham, J. (1992). Personal correspondence.
- Oakley, A. (1984). The Captured Womb. Oxford, England: Blackwell Publishing.
- Reece, L. (1935). The estimation of fetal maturity by a new method of x-ray
cephalometry: its bearing on clinical midwifery. Proc Royal Soc Med 18.
- Salmond, R. (1937). The uses and values of radiology in obstetrics. In F. Browne
(Ed), Antenatal and Postnatal Care (2nd ed.). London: J. & A. Churchill.
- Salveson, K. et al. (1993). Routine ultrasonography in utero and subsequent
handedness and neurological development. British Medical Journal 307.
- World Health Organisation. (1984). Diagnostic ultrasound in pregnancy: WHO view
on routine screening. Lancet 2.
Excerpted and adapted from Pursuing
the Birth Machine: The Search for Appropriate Birth Technology, copyright
1994 by Marsden Wagner, published by ACE Graphics. Available in the United
States and Canada from the ICEA Bookcenter, (800) 624-4934; Fax (612)
854-8772.
Marsden Wagner, MD is a neonatologist and perinatal epidemiologist.
He was responsible for maternal and child health in the European Regional Office
of the World Health Organization for fourteen years. Now living in Washington, D.C.,
he travels the world talking about appropriate uses of technology in birth and utilizing
midwives for the best outcome.
Related Information:
If you enjoyed this article, you'll enjoy Midwifery Today magazine!
Subscribe
now!
|